Tenzing Acquisition Corp. Uncategorized Contracts & Agreements
16 Contracts & Agreements
- Description of Securities (Filed With SEC on April 15, 2024)
- Description of Securities (Filed With SEC on March 30, 2023)
- Description of Securities (Filed With SEC on March 22, 2021)
- Letter Agreement, dated as of December 14, 2020, by and between the Company, Maxim Group LLC and Maxim Partners LLC (Filed With SEC on December 18, 2020)
- Form of Assumed Option (Filed With SEC on December 18, 2020)
- Letter Agreement, dated as of March 15, 2016, by and between Marc Cantillon, MD and Reviva Pharmaceuticals, Inc (Filed With SEC on December 18, 2020)
- Letter Agreement, dated as of October 28, 2015, by and between Marc Cantillon, MD and Reviva Pharmaceuticals, Inc (Filed With SEC on December 18, 2020)
- Form of Backstop Agreement, by and among Tenzing Acquisition Corp., Reviva Pharmaceuticals, Inc., and the Investor named therein (Filed With SEC on October 22, 2020)
- Lock-Up Agreement, dated as of July 20, 2020 by and among Dr. Bhat, Tenzing and the Purchaser Representative (Filed With SEC on July 24, 2020)
- Form of Lock-Up Agreement (General) (Filed With SEC on July 24, 2020)
- Description of the Registrants securities registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended (Filed With SEC on May 4, 2020)
- Letter Agreement, dated August 20, 2018, by and among the Company, its officers, its directors and the Sponsor (Filed With SEC on August 24, 2018)
- Form of Indemnity Agreement (Filed With SEC on August 6, 2018)
- Form of Letter Agreement among the Registrant and each of the sponsor, directors and officers of the Registrant (Filed With SEC on August 6, 2018)
- Specimen Ordinary Shares Certificate (Filed With SEC on August 6, 2018)
- Specimen Unit Certificate (Filed With SEC on August 6, 2018)
